Hansen Gwenn

CIK 00018171601 companyBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001817160

Recent Transactions

50 trades

Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2026-06-25$20.00/sh−5,394→ 115,005 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2026-04-30+3,750→ 120,755 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2026-04-30+2,000→ 117,005 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2026-04-30−2,858→ 22,867 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2026-04-30−3,750→ 15,000 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2026-04-30+2,858→ 123,613 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2026-04-30$16.65/sh−3,214→ 120,399 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2026-04-30−2,000→ 0 total
Award
Nurix Therapeutics, Inc.$NRIX
Employee Stock Option (right to buy)
2026-02-10+93,750→ 93,750 total
Award
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2026-02-10+42,875→ 42,875 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Employee Stock Option (right to buy)
2026-02-03−31,333→ 0 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2026-02-03$0.84/sh+31,333→ 115,005 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2026-01-30+2,000→ 81,958 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2026-01-30−2,859→ 25,725 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2026-01-30+3,750→ 85,708 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2026-01-30+2,859→ 88,567 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2026-01-30−3,750→ 18,750 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2026-01-30−3,207→ 0 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2026-01-30+3,207→ 79,958 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2026-01-30$16.58/sh−4,797→ 83,770 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2026-01-30$17.37/sh−98→ 83,672 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2026-01-30−2,000→ 2,000 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-10-30−3,207→ 3,207 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-10-30+3,207→ 72,230 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-10-30−2,858→ 28,584 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-10-30+2,000→ 74,230 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-10-30+3,750→ 77,980 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-10-30−3,750→ 22,500 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-10-30$12.80/sh−4,087→ 76,751 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-10-30−2,000→ 4,000 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-10-30+2,858→ 80,838 total
Award
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-10-14+20,000→ 20,000 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-07-30+3,750→ 70,473 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-07-30+2,858→ 73,331 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-07-30+2,000→ 66,723 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-07-30−2,000→ 6,000 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-07-30−3,750→ 26,250 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-07-30−3,207→ 6,414 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-07-30−2,858→ 31,442 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-07-30+3,207→ 64,723 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-07-30$12.01/sh−4,308→ 69,023 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-04-30+3,206→ 59,143 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-04-30−3,750→ 30,000 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-04-30−2,000→ 8,000 total
Sale
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-04-30$11.50/sh−3,377→ 61,516 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-04-30+2,000→ 61,143 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Common Stock
2025-04-30+3,750→ 64,893 total
Exercise/Conversion
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-04-30−3,206→ 9,621 total
Award
Nurix Therapeutics, Inc.$NRIX
Employee Stock Option (right to buy)
2025-02-11+75,000→ 75,000 total
Award
Nurix Therapeutics, Inc.$NRIX
Restricted Stock Units
2025-02-11+34,300→ 34,300 total

Companies

Nurix Therapeutics, Inc.
Chief Scientific Officer
$NRIX

Recent Filings

Address

C/O NURIX THERAPEUTICS, INC. 1600 SIERRA POINT PKWY

BRISBANE, CA, 94005

View on SEC.gov